Second Genome CEO Predicts Paradigm Shift With Microbiome Discovery
California biotech, which has backing from major pharmas, explains the application of its microbiome discovery platform to multiple disease types.
California biotech, which has backing from major pharmas, explains the application of its microbiome discovery platform to multiple disease types.